Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,703 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Colistin: an update on the antibiotic of the 21st century.
Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM. Biswas S, et al. Expert Rev Anti Infect Ther. 2012 Aug;10(8):917-34. doi: 10.1586/eri.12.78. Expert Rev Anti Infect Ther. 2012. PMID: 23030331 Review.
Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.
Biswas S, Dubus JC, Reynaud-Gaubert M, Stremler N, Rolain JM. Biswas S, et al. Eur J Clin Microbiol Infect Dis. 2013 Nov;32(11):1461-4. doi: 10.1007/s10096-013-1898-5. Epub 2013 May 30. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23719852
For S. maltophilia, 25 out of 27 isolates had low minimum inhibitory concentrations (MICs, 0.125-0.75 mg/L), whereas two isolates displayed high MICs (32 mg/L). ...Colistin displayed excellent activity against S. maltophilia and A. xylosoxidans and the disk diffusio …
For S. maltophilia, 25 out of 27 isolates had low minimum inhibitory concentrations (MICs, 0.125-0.75 mg/L), whereas two isolates dis …
Molecular characterisation of resistance to rifampin in Bartonella quintana.
Biswas S, Raoult D, Rolain JM. Biswas S, et al. Clin Microbiol Infect. 2009 Dec;15 Suppl 2:100-1. doi: 10.1111/j.1469-0691.2008.02179.x. Epub 2009 Dec 24. Clin Microbiol Infect. 2009. PMID: 19929979 No abstract available.
Molecular mechanism of gentamicin resistance in Bartonella henselae.
Biswas S, Raoult D, Rolain JM. Biswas S, et al. Clin Microbiol Infect. 2009 Dec;15 Suppl 2:98-9. doi: 10.1111/j.1469-0691.2008.02178.x. Clin Microbiol Infect. 2009. PMID: 20584166 No abstract available.
Bartonella infection: treatment and drug resistance.
Biswas S, Rolain JM. Biswas S, et al. Future Microbiol. 2010 Nov;5(11):1719-31. doi: 10.2217/fmb.10.133. Future Microbiol. 2010. PMID: 21133691 Review.
Bartonella species are responsible for different clinical conditions affecting humans, including Carrion's disease, cat scratch disease, trench fever, bacillary angiomatosis, endocarditis and peliosis hepatis. ...
Bartonella species are responsible for different clinical conditions affecting humans, including Carrion's disease, cat scratch disea …
A bioinformatic approach to understanding antibiotic resistance in intracellular bacteria through whole genome analysis.
Biswas S, Raoult D, Rolain JM. Biswas S, et al. Int J Antimicrob Agents. 2008 Sep;32(3):207-20. doi: 10.1016/j.ijantimicag.2008.03.017. Epub 2008 Jul 10. Int J Antimicrob Agents. 2008. PMID: 18619818 Review.
Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
Angelakis E, Biswas S, Taylor C, Raoult D, Rolain JM. Angelakis E, et al. Among authors: biswas s. J Antimicrob Chemother. 2008 Jun;61(6):1252-5. doi: 10.1093/jac/dkn094. Epub 2008 Mar 10. J Antimicrob Chemother. 2008. PMID: 18334491
Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis.
Biswas S, Raoult D, Rolain JM. Biswas S, et al. J Antimicrob Chemother. 2007 Jun;59(6):1065-70. doi: 10.1093/jac/dkm105. Epub 2007 Apr 21. J Antimicrob Chemother. 2007. PMID: 17449882
OBJECTIVES: Bartonella bacilliformis is the aetiological agent of Carrion's disease. Although ciprofloxacin, rifampicin and erythromycin have been successfully used in the treatment of the disease, failures and relapses have been reported. ...CONCLUSIONS: According with th …
OBJECTIVES: Bartonella bacilliformis is the aetiological agent of Carrion's disease. Although ciprofloxacin, rifampicin and erythromy …
2,703 results
Jump to page
Feedback